Fall 2014 Issue of BioMatters Now Available
Monday, October 6, 2014
Posted by: Katie Trevathan
We’re pleased to share with you the 10th issue of BioMatters™, which highlights the very best of Michigan’s biosciences industry.
The stories show plenty and varied examples of remarkable discovery, technology, talent, and human compassion. Collectively they describe how research, development, and manufacturing efforts are leading to new products that are benefiting the health and welfare of humankind.
Michigan’s advantage in knowledge, people, and entrepreneurial spirit is full-grown. The last decade has witnessed the implementation of support service programs, investment funding and attraction, business incentives, and talent enhancement initiatives, while creating a culture of risk-taking.
The resulting bio-industry ecosystem is robust and has spawned the birth of almost two hundred new startups. Our feature article (p.6) describes how some of these companies have realized commercial success and are creating a pipeline of innovation and business growth, and then introduces you to the latest crop of entrepreneurs as we profile their bioscience ventures.
With that as a backdrop, this BioMatters issue visits with a spectrum of other educational, academic research, and private sector enterprises.
Our world-renowned universities and colleges are leading the way! Read how Kettering University’s learning model allows students to become exceptionally qualified to enter the biosciences workforce (p.19). Similarly, Wayne State University is implementing its NIH-funded BEST program to develop skilled bioscience talent (p.10).
On the research front, the Center for Chemical Genomics at the University of Michigan’s Life Science Institute is engaged in identifying potential drug candidates (p.27); the Bioeconomy Institute at Michigan State University, a former Pfizer production facility, is now providing contract scale up and de-risking services while serving as a regional business incubator funded by the federal government’s i6 program (p.22); and The Front Door at Wayne State is truly opening doors for industry collaborations (p.12).
The biosciences private sector is booming. Grand Rapids-based Medbio (p.31) has become the vendor of choice for many multi-national biopharma companies and small biotech startups. Paradigm, a recent public-private joint venture is ushering in the age of personalized medicine and helping doctors to tailor cancer treatments for their patients (p.14). Learn how Xoran Technologies is revolutionizing point-of-care imaging (p.17). Lastly, Avomeen, a four-year old company, is rapidly expanding its contract pharmaceutical sciences and manufacturing services to biopharma clients (p.29).
Want to discover more of Michigan’s bio-industry? Then peruse archived issues of BioMatters at www.michbio.org/biomatters. Let MichBio connect you to Michigan’s bioscience companies, business services, assets, and markets!
BioMatters is published twice per year. Information about submitting an article and advertising opportunities can be found here. Subscribe to BioMatters here.
Download the PDF or browse through the issue below to see how Michigan is setting a foundation for growth: